Introduction:

Thrombotic disease associated with malignant hemopathies is underestimated in critically ill patients; sometimes it remains in the shadow of the hemorrhages that these patients present. Its diagnosis and treatment constitute a challenge to achieve increased survival in these patients in critical care units

Objectives:

To analyze the general aspects of thrombotic alterations in seriously ill patients with malignant hemopathies.

Methods:

A bibliographical-documentary research on the subject was carried out. The SciELO and Pubmed databases of the last ten years were consulted.

Analysis and synthesis of the information:

General aspects related to the coagulation mechanism, its diagnostic criteria are described; as well as the evolution of the patient with thrombosis who is admitted to the intensive care unit.

Conclusions:

Knowledge of thromboembolic alterations in patients with malignant hemopathies allows adequate monitoring and the creation of individual strategies to improve the survival of these patients in the ICU.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )